Informação sobre produto
- MK 0777
- 1,2,4-Triazolo[4,3-b]pyridazine, 7-(1,1-dimethylethyl)-6-[(1-ethyl-1H-1,2,4-triazol-5-yl)methoxy]-3-(2-fluorophenyl)-
- 7-(1,1-Dimethylethyl)-6-[(1-ethyl-1H-1,2,4-triazol-5-yl)methoxy]-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine
TPA 023 is a drug that is used in the treatment of anxiety and depression. It has been found to bind with benzodiazepine binding sites, which are receptors that are located on the surface of neurons. These receptors are activated by benzodiazepines, which can cause sedation and relieve anxiety. TPA 023 binds with high affinity to the α1 subunit of GABA-A receptor, which is responsible for mediating neuronal inhibition. TPA 023 has been shown to inhibit the release of epidermal growth factor (EGF) in cultured cells, suggesting that it may be useful in treating skin conditions such as psoriasis. It also inhibits the activity of lorazepam, a nonselective GABA-A receptor agonist.
Propriedades químicas
Consulta técnica sobre: 3D-CKA97751 TPA 023
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
